Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line

PURPOSE: Clinical control of corticotroph tumors is difficult to achieve since they usually persist or relapse after surgery. Pasireotide is approved to treat patients with Cushing’s disease for whom surgical therapy is not an option. However, Pasireotide seems to be effective only in a sub-set of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentilin, E., Borges De Souza, P., Ambrosio, M. R., Bondanelli, M., Gagliardi, I., Zatelli, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632222/
https://www.ncbi.nlm.nih.gov/pubmed/37233978
http://dx.doi.org/10.1007/s40618-023-02117-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632222/
https://www.ncbi.nlm.nih.gov/pubmed/37233978
http://dx.doi.org/10.1007/s40618-023-02117-0

Ejemplares similares